Thomas James Gunderson - Feb 28, 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Feb 28, 2025
Transactions value $
-$17,460
Form type
4
Date filed
3/3/2025, 08:19 PM
Previous filing
May 28, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $1.26M +25K +115.27% $50.50 46.7K Feb 28, 2025 Direct
transaction MMSI Common Stock, No Par Value Tax liability -$1.28M -12.8K -27.43% $99.95 33.9K Feb 28, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -25K -100% $0.00 0 Feb 28, 2025 Common Stock 25K $50.50 Direct F2
holding MMSI Non-qualified stock options (right to buy) 13.8K Feb 28, 2025 Common Stock 13.8K $52.17 Direct F3
holding MMSI Non-qualified stock options (right to buy) 7.5K Feb 28, 2025 Common Stock 7.5K $52.17 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.60 to $100.515, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F3 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F4 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.